“The existing condition has uncovered some structural weaknesses within the EU’s medicines provide chain as well as a substantial dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides said. She encouraged that provide chain problems be dealt with in an EU pharmaceutical method envisioned for being re